Sec Form 13G Filing - D. E. SHAW & CO L.P. filing for AMBRX BIOPHARMA INC (AMAM) - 2023-03-16

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

SCHEDULE 13G 

 

 

Under the Securities Exchange Act of 1934

 

 

Ambrx Biopharma Inc.

(Name of Issuer) 

 

 

Ordinary shares, $0.0001 par value per share

(Title of Class of Securities)

 

 

02290A102(1)

(CUSIP Number)

  

 

March 6, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the following box to designate the rule pursuant to which the Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

1 The CUSIP reported herein applies to the Issuer’s American Depositary Shares (“ADS”), each representing seven ordinary shares.

 

 

 

 

 

 

CUSIP No. 02290A102

 

  1.

Names of Reporting Persons

D. E. Shaw Valence Portfolios, L.L.C.

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
   

(b)

 

¨
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

Delaware

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

16,537,500(2)

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

16,537,500(2)

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

16,537,500(2)

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

 

  11.

Percent of Class Represented by Amount in Row (9)

6.1%(3)

 

  12.

Type of Reporting Person (See Instructions)

OO

  

 

2 The number of shares beneficially owned consists of ordinary shares represented by ADS.

3 Based upon 270,328,483 ordinary shares outstanding as of June 30, 2022, as reported in Exhibit 99.1 of the Issuer’s August 29, 2022 Form 6-K.

 

 

 

 

CUSIP No. 02290A102

 

  1.

Names of Reporting Persons

D. E. Shaw & Co., L.L.C.

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
   

(b)

 

¨
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

Delaware

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

22,050,000(2)

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

22,050,000(2)

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

22,050,000(2)

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

 

  11.

Percent of Class Represented by Amount in Row (9)

8.2%(3)

 

  12.

Type of Reporting Person (See Instructions)

OO

 

 

2 The number of shares beneficially owned consists of ordinary shares represented by ADS.

3 Based upon 270,328,483 ordinary shares outstanding as of June 30, 2022, as reported in Exhibit 99.1 of the Issuer’s August 29, 2022 Form 6-K.

 

 

 

CUSIP No. 02290A102

 

  1.

Names of Reporting Persons

D. E. Shaw & Co., L.P.

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
   

(b)

 

¨
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

Delaware

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

22,050,000(2)

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

22,050,000(2)

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

22,050,000(2)

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

 

  11.

Percent of Class Represented by Amount in Row (9)

8.2%(3)

 

  12.

Type of Reporting Person (See Instructions)

IA, PN

 

 

2 The number of shares beneficially owned consists of ordinary shares represented by ADS.

3 Based upon 270,328,483 ordinary shares outstanding as of June 30, 2022, as reported in Exhibit 99.1 of the Issuer’s August 29, 2022 Form 6-K.

 

 < /div>

 

 

CUSIP No. 02290A102

 

  1.

Names of Reporting Persons

David E. Shaw

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
   

(b)

 

¨
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

United States

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

22,050,000(2)

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

22,050,000(2)

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

22,050,000(2)

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

 

  11.

Percent of Class Represented by Amount in Row (9)

8.2%(3)

 

  12.

Type of Reporting Person (See Instructions)

IN

   

 

2 The number of shares beneficially owned consists of ordinary shares represented by ADS.

3 Based upon 270,328,483 ordinary shares outstanding as of June 30, 2022, as reported in Exhibit 99.1 of the Issuer’s August 29, 2022 Form 6-K.

 

 

 

 

Item 1.
  (a) Name of Issuer
   

  Ambrx Biopharma Inc.

   
  (b) Address of Issuer's Principal Executive Offices
   

  10975 Torrey Pines Road

  La Jolla, California 92037

   
Item 2.
  (a) Name of Person Filing
   

  D. E. Shaw Valence Portfolios, L.L.C.

  D. E. Shaw & Co., L.L.C.

  D. E. Shaw & Co., L.P.

  David E. Shaw

   
  (b) Address of Principal Business Office or, if none, Residence
   

  The business address for each reporting person is:

  1166 Avenue of the Americas, 9th Floor

  New York, NY 10036

   
  (c) Citizenship
   

  D. E. Shaw Valence Portfolios, L.L.C. is a limited liability company organized under the laws of the state of Delaware.

  D. E. Shaw & Co., L.L.C. is a limited liability company organized under the laws of the state of Delaware.

  D. E. Shaw & Co., L.P. is a limited partnership organized under the laws of the state of Delaware.

  David E. Shaw is a citizen of the United States of America.

   
  (d) Title of Class of Securities
   

  Ordinary shares, $0.0001 par value per share

   
  (e) CUSIP Number
   

  02290A102

   
Item 3.

If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

 

Not Applicable

 

Item 4.

Ownership

 

As of March 6, 2023:

  

(a) Amount beneficially owned:  
     
  D. E. S haw Valence Portfolios, L.L.C.: 16,537,500 shares
     
  D. E. Shaw & Co., L.L.C.:

22,050,000 shares

This is composed of (i) 16,537,500 shares in the name of D. E. Shaw Valence Portfolios, L.L.C. and (ii) 5,512,500 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C.

 

 

D. E. Shaw & Co., L.P.: 

 

22,050,000 shares

This is composed of (i) 16,537,500 shares in the name of D. E. Shaw Valence Portfolios, L.L.C. and (ii) 5,512,500 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C.

 

 

David E. Shaw:

 

22,050,000 shares

This is composed of (i) 16,537,500 shares in the name of D. E. Shaw Valence Portfolios, L.L.C. and (ii) 5,512,500 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C.

 

 

 

 

(b)Percent of class:

  D. E. Shaw Valence Portfolios, L.L.C.: 6.1%
  D. E. Shaw & Co., L.L.C.:

8.2%

  D. E. Shaw & Co., L.P.:

8.2%

  David E. Shaw:

8.2%

 

(c)Number of shares to which the person has:
(i)Sole power to vote or to direct the vote:
  D. E. Shaw Valence Portfolios, L.L.C.: -0- shares
  D. E. Shaw & Co., L.L.C.:

-0- shares

  D. E. Shaw & Co., L.P.:

-0- shares

  David E. Shaw:

-0- shares

 

(ii)Shared power to vote or to direct the vote:

  D. E. Shaw Valence Portfolios, L.L.C.: 16,537,500 shares
  D. E. Shaw & Co., L.L.C.:

22,050,000 shares

  D. E. Shaw & Co., L.P.:

22,050,000 shares

  David E. Shaw:

22,050,000 shares

 

(iii)Sole power to dispose or to direct the disposition of:
  D. E. Shaw Valence Portfolios, L.L.C.: -0- shares
  D. E. Shaw & Co., L.L.C.:

-0- shares

  D. E. Shaw & Co., L.P.:

-0- shares

  David E. Shaw:

-0- shares

 

(iv)Shared power to dispose or to direct the disposition of:
  D. E. Shaw Valence Portfolios, L.L.C.: 16,537,500 shares
  D. E. Shaw & Co., L.L.C.:

22,050,000 shares

  D. E. Shaw & Co., L.P.:

22,050,000 shares

  David E. Shaw:

22,050,000 shares

 

David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P., which in turn is the investment adviser of D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C., and by virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which in turn is the manager of D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, the 22,050,000 shares as described above constituting 8.2% of the outstanding shares and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares. David E. Shaw disclaims beneficial ownership of such 22,050,000 shares.

 

Item 5. Ownership of Five Percent or Less of a Class

Not Applicable

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group

Not Applicable

 

Item 9. Notice of Dissolution of Group

Not Applicable

 

Item 10. Certification

By signing below, each of D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., and David E. Shaw certify that, to the best of such reporting person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purposes or effect.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Powers of Attorney, dated March 1, 2017, granted by David E. Shaw in favor of Nathan Thomas, are attached hereto.

 

Dated: March 16, 2023

  

 

  D. E. Shaw Valence Portfolios, L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory

 

 

  D. E. Shaw & Co., L.L.C.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Authorized Signatory

 

 

  D. E. Shaw & Co., L.P.
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Chief Compliance Officer

  

 

  David E. Shaw
   
  By: /s/ Nathan Thomas
    Nathan Thomas
    Attorney-in-Fact for David E. Shaw